WASHINGTON, July 24 -- The U.S. Department of Justice's U.S. Attorney's office for XXXXXX (insert district) issued the following press release:
SAN FRANCISCO - Santa Clara-based Lin-Zhi International, Inc. (LZI) has agreed to pay a total of $180,835 to the United States and implement an enhanced Drug Enforcement Administration (DEA) compliance program to resolve allegations that LZI, a DEA-registered manufacturer of controlled substances, violated the Controlled Substances Act (CSA) in connection with its manufacturing and distribution of certain controlled substances.
LZI is registered with the DEA to manufacture controlled substances as bulk reagents for drug abuse testing. To the extent registrants like LZI seek to distribute these dru...